Market Alert: Ukraine Conflict Update and U.S. Policy Risk

Visionflex Limited Reports Strong Growth with Expanding Telehealth Adoption

Aug 29, 2025

Visionflex Limited (ASX: VFX) delivered a positive update for FY25, reporting robust growth as demand for its telehealth solutions continues to expand across domestic and international markets. The company recorded revenue of AU$9.8 million, up 23% year-on-year, supported by increased adoption of its ProEX telehealth platform and integration of advanced diagnostic tools (financial snapshot, page 3). Gross margins improved to 62%, reflecting higher subscription revenue and efficiency gains in software deployment. Visionflex also secured new distribution partnerships in Asia and Europe, widening its customer base among hospitals, clinics, and government health services (map, page 5). The company closed the year with AU$4.2 million in cash reserves, providing a strong platform for continued growth. Management reaffirmed its strategy to scale recurring revenues, expand SaaS offerings, and strengthen its global footprint in digital healthcare, positioning Visionflex as a leader in connected telehealth solutions.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com